Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cihan Uras

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
European Journal of Breast Health|March 24, 2026
Evolving Concepts and Contemporary Management of Early-Stage Breast Cancer: An Evidence-Based Approach to Grey Zones from a Comprehensive Breast Unit Part 1: Locoregional Therapy, Pathology, RadiologyElif Şenocak Taşçı, Halil Kara, Emir Çapkınoğlu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2020
The role of loco-regional treatment in long-term quality of life in de novo stage IV breast cancer patients: protocol MF07-01QAtilla Soran, Aykut Soyder, Serdar Ozbas, et al.
Clinical Breast Cancer|March 7, 2025
Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO StudyNeslihan Cabıoğlu, Hasan Karanlık, Vahit Özmen, et al.
Frontiers in Oncology|July 14, 2023
Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of TurkeyÇağlar Ünal, Tolga Özmen, Çetin Ordu, et al.
Annals of Surgical Oncology|February 3, 2021
The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry StudyAtilla Soran, Lutfi Dogan, Arda Isik, et al.
Annals of Surgical Oncology|May 20, 2018
Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01Atilla Soran, Vahit Ozmen, Serdar Ozbas, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 29, 2025
Poor Prognostic Clinicopathological Features of Young Women with Breast Cancer in the MF18-04 Turkish National Breast Cancer Registry StudyNeslihan Cabıoğlu, Zeliha Türkyılmaz, Enver Özkurt, et al.
Current Oncology (Toronto, Ont.)|October 28, 2025
Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1aAtilla Soran, Berk Göktepe, Berkay Demirors, et al.
JAMA Surgery|January 2, 2025
De-Escalation of Nodal Surgery in Clinically Node-Positive Breast CancerNeslihan Cabioglu, Havva Belma Koçer, Hasan Karanlik, et al.
Cancer|October 30, 2024
Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies: ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is providedMahmut Muslumanoglu, Neslihan Cabioglu, Abdullah Igci, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
European Journal of Breast Health|March 24, 2026
Evolving Concepts and Contemporary Management of Early-Stage Breast Cancer: An Evidence-Based Approach to Grey Zones from a Comprehensive Breast Unit Part 1: Locoregional Therapy, Pathology, RadiologyElif Şenocak Taşçı, Halil Kara, Emir Çapkınoğlu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2020
The role of loco-regional treatment in long-term quality of life in de novo stage IV breast cancer patients: protocol MF07-01QAtilla Soran, Aykut Soyder, Serdar Ozbas, et al.
Clinical Breast Cancer|March 7, 2025
Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO StudyNeslihan Cabıoğlu, Hasan Karanlık, Vahit Özmen, et al.
Frontiers in Oncology|July 14, 2023
Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of TurkeyÇağlar Ünal, Tolga Özmen, Çetin Ordu, et al.
Annals of Surgical Oncology|February 3, 2021
The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry StudyAtilla Soran, Lutfi Dogan, Arda Isik, et al.
Annals of Surgical Oncology|May 20, 2018
Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01Atilla Soran, Vahit Ozmen, Serdar Ozbas, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 29, 2025
Poor Prognostic Clinicopathological Features of Young Women with Breast Cancer in the MF18-04 Turkish National Breast Cancer Registry StudyNeslihan Cabıoğlu, Zeliha Türkyılmaz, Enver Özkurt, et al.
Current Oncology (Toronto, Ont.)|October 28, 2025
Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1aAtilla Soran, Berk Göktepe, Berkay Demirors, et al.
JAMA Surgery|January 2, 2025
De-Escalation of Nodal Surgery in Clinically Node-Positive Breast CancerNeslihan Cabioglu, Havva Belma Koçer, Hasan Karanlik, et al.
Cancer|October 30, 2024
Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies: ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is providedMahmut Muslumanoglu, Neslihan Cabioglu, Abdullah Igci, et al.
Pageof 9